Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FATTAX: Pharmacokinetics of Docetaxel in Localized Breast Cancer
NCT05858398Recruiting
- Sponsor
- Centre Henri Becquerel
- Start
- Oct 2023
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of docetaxel in breast cancer, sponsored by Centre Henri Becquerel. Primary endpoint: Area Under the Curve of Docetaxel at 8 hours. Started Oct 2023; status: recruiting.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05858398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05858398.